Form 4 for CRL Charles River Laboratories
Accepted 2024-05-29 00:00:00 ET · period of report 2024-05-29 · accession 0001127602-24-016818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-29 | 2024-05-29 | CRL | Girshick Birgit | COO, Corp. Executive VP | F - Tax | $214.51 | -216 | 46.7K | -0.5% | -$46.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-29 | F | D | 216 | $214.51 | 46,674 | D | — | — |